A simple innovation the size of a grain of sand means we can now analyse cells and tiny particles as if they were inside the human body.
The new micro-device for fluid analysis will enable more tailored experiments in drug development and disease research.
It could also transform water contamination testing and medical diagnosis in natural disaster zones, where its low cost, simple use and portability make it a practical tool almost anyone can use.
How it works
Microfluidic or ‘lab-on-a-chip’ devices are commonly used to analyse blood and other fluid samples, which are pumped through narrow channels in a transparent chip the size of a postage stamp.
These miniaturised chips are made using state-of-the-art device fabrication facilities at RMIT’s Micro Nano Research Facility.
This new chip takes that technology one step further by adding a three-dimensional cavity along the channel – think of a narrow tunnel that suddenly opens into a domed vault – which creates a mini-vortex where particles spin around, making them easier to observe.
To make this cavity, researchers inserted a liquid metal drop onto the silicon mould when making the chip.
The liquid metal’s high surface tension means it holds its form during the moulding process.
Finally the liquid metal is removed, leaving just the channel and a spherical cavity ready to use as a mini-centrifuge, explained RMIT engineer and study co-leader Dr Khashayar Khoshmanesh.
“When the fluid sample enters the spherical-shaped cavity, it spins inside the cavity,” he said.
“This spinning creates a natural vortex, which just like a centrifuge machine in an analytics lab, spins the cells or other biological samples, allowing them to be studied without the need for capturing or labelling them.”
The device only requires tiny samples, as little as 1 ml of water or blood, and can be used to study tiny bacterial cells measuring just 1 micron, all the way up to human cells as large as 15 microns.
A platform for studying cardiovascular diseases
Study co-leader and RMIT Postdoctoral Research Fellow, Dr Sara Baratchi, said the device’s soft spherical cavities could be used to mimic 3D human organs and observe how cells behave in various flow conditions or drug interactions.
“The ability to tailor the size of the cavity also allows for different flow situations to be simulated – this way we can mimic the response of blood cells under disturbed flow situations, for example at branch points and curvatures of coronary and carotid arteries, which are more prone to narrowing,” she said.
This capability will be of interest to Australia’s booming biomedical industry, with medical apparatus being among our top 10 exports in 2018 and worth $3.2 billion.
Baratchi said the discovery was only made possible through collaboration, with technologists from the School of Engineering and mechano-biologists in the School of Health and Biomedical Sciences joining forces in RMIT’s Mechanobiology and Microfluidics research group.
“Biologists like myself have been struggling to study the impact of flow-associated forces on circulatory blood cells. Now this miniaturised device developed with our engineering colleagues does exactly that,” Baratchi said.
“It’s an ingenious solution that really highlights the value of cross-disciplinary research.”
But some of the most exciting applications could also be outside the lab.
A cheap and portable water test that anyone can use
Another promising application is for identifying parasites and other infections in waterways, especially in developing countries.
“Detection of water impurities can be a difficult task because you don’t always know exactly what you’re looking for,” Khoshmanesh said.
“But with this device the impurities will be captured and orbited by the vortex without any special sample preparation, saving time and money.”
Whether used for analysing water or blood samples, the low cost and portability of the device makes it attractive for a whole range of applications.
The same research group recently developed a pressure pump, made from latex balloons, to operate the device.
Unlike conventional pumps, which can be as large as a shoebox and cost thousands of dollars, theirs is low cost and portable.
“Simplicity is a very important parameter for our designs because that often translates to lower cost and great applicability outside the lab,” Khoshmanesh said.
“Our new microfluidic device, combined with our pump and a smartphone capable of capturing high-speed images, makes a low-cost, self-sufficient and entirely portable point-of-care diagnostics device.”
The Latest on: Point-of-care diagnostics device
via Google News
The Latest on: Point-of-care diagnostics device
- Kessler Topaz Meltzer & Check, LLP: Securities Fraud Class Action Filed Against Chembio Diagnostics, Inc. - CEMIon July 9, 2020 at 3:29 pm
The law firm of Kessler Topaz Meltzer & Check, LLP alerts investors that a securities fraud class action lawsuit has been filed against Chembio Diagnostics, Inc. (NASDAQ: CEMI) ("Chembio") on behalf ...
- COVID-19 spurs wave of innovative diagnosticson July 8, 2020 at 11:00 am
Coronavirus is instigating new thinking in diagnostics, such as face masks that can detect viruses on a wearer’s breath or paper-based microfluidics for pathogen identification in low-resource ...
- Microfluidic Devices Market Opportunities Analysis Forecast By 2024on July 7, 2020 at 10:45 pm
Global Microfluidic Devices Market is estimated to reach $14.3 Billion by 2024; growing at a CAGR of 22.5% from 2016 ...
- Pomerantz Law Firm Announces the Filing of a Class Action against Chembio Diagnostics, Inc. and Certain Officers - CEMIon July 6, 2020 at 5:36 pm
Pomerantz LLP announces that a class action lawsuit has been filed against Chembio Diagnostics, Inc. ("Chembio" or the "Company") ...
- Coronavirus (COVID-19) Update: FDA Issued Emergency Use Authorization for Point of Care Antigen Teston July 6, 2020 at 10:35 am
Today’s authorization is another achievement of that work. Antigen tests play an important role in the overall response against COVID-19, including as a point-of-care test that can potentially scale ...
- WHO endorses Truenat molecular diagnostic tests for TBon July 3, 2020 at 6:32 am
The Foundation for Innovative New Diagnostics, Molbio Diagnostics and the Indian Council of Medical Research announced today that the World Health Organization has now endorsed three of their rapid ...
- Diagnostics firm Eurofins launches new coronavirus test deviceson June 30, 2020 at 11:03 pm
French diagnostics company Eurofins Technologies EUFI.PA announced on Wednesday the launch of new devices aimed at testing for the presence of COVID-19, ...
- Eurofins Technologies Launches Rapid Point-of-Care Testing Devices That Identify Exposure to COVID-19 in Only 10 Minuteson June 30, 2020 at 10:30 pm
Regulatory News: Eurofins Technologies (Paris:ERF) announces the launch of CE-IVD marked rapid point-of-care testing devices to identify a person’s pa ...
- Meet the 5 diagnostics finalists for INVEST Pitch Perfect contest. Register now to get the Earlybird rate.on June 30, 2020 at 1:03 pm
In the diagnostics track of the online pitch contest, five companies will present their technologies, which span early detection of pancreatic cancer to liquid biopsies. Register now!
- Tuberculosis Diagnostics Market – Tuberculosis diagnostics devices are proving to be beneficial for rapid COVID-19 testingon June 29, 2020 at 10:44 pm
The tuberculosis diagnostics market may experience a meteoric rise in the growth rate during the forecast period of 2019-2029 with various initiatives and ...
via Bing News